Keyword search (4,164 papers available)

"Insomnia" Keyword-tagged Publications:

Title Authors PubMed ID
1 Perceptions et attitudes des personnes âgées souffrant d insomnie par rapport aux médicaments et aux produits de santé naturels Nguyen PV; Dang-Vu T; Forest G; Saidi L; Desmarais P; 40968485
CONCORDIA
2 Relationship Between Lumbar Multifidus Morphometry and Pain/Disability in Individuals With Chronic Nonspecific Low Back Pain After Considering Demographics, Fear-Avoidance Beliefs, Insomnia, and Spinal Degenerative Changes Pinto SM; Cheung JPY; Samartzis D; Karppinen J; Zheng YP; Pang MYC; Fortin M; Wong AYL; 40376565
SOH
3 Efficacy of cognitive behavioral therapy for insomnia and lemborexant medication for different subtypes of chronic insomnia: study protocol for a randomized controlled trial Chen SJ; Ivers H; Dang-Vu TT; Shapiro CM; Carney CE; Robillard R; Morin CM; 40346496
HKAP
4 Cognitive-behavioural therapy for insomnia mechanism of action: Exploring the homeostatic K-complex involvement Sforza M; Morin CM; Dang-Vu TT; Pomares FB; Perrault AA; Gouin JP; Bušková J; Janku K; Vgontzas A; Fernandez-Mendoza J; Bastien CH; Riemann D; Baglioni C; Carollo G; Casoni F; Zucconi M; Castronovo V; Galbiati A; Ferini-Strambi L; 39739397
SOH
5 Effect of age on hypnotics' efficacy and safety in insomnia: A systematic review and meta-analysis Patrick Viet-Quoc N; Thien Thanh DV; Philippe L; Sebastien C; Lidia S; Philippe D; 39603114
CONCORDIA
6 Trends in nighttime insomnia symptoms in Canada from 2007 to 2021 Chaput JP; Morin CM; Robillard R; Carney CE; Dang-Vu TT; Davidson JR; Tomkinson GR; Lang JJ; 39556998
HKAP
7 Delphi consensus recommendations for the management of chronic insomnia in Canada Morin CM; Khullar A; Robillard R; Desautels A; Mak MSB; Dang-Vu TT; Chow W; Habert J; Lessard S; Alima L; Ayas NT; MacFarlane J; Kendzerska T; Lee EK; Carney CE; 39481275
HKAP
8 Prevalence of insomnia and use of sleep aids among adults in Canada Morin CM; Vézina-Im LA; Chen SJ; Ivers H; Carney CE; Chaput JP; Dang-Vu TT; Davidson JR; Belleville G; Lorrain D; Horn O; Robillard R; 39369578
HKAP
9 Predicting response to stepped-care cognitive behavioral therapy for insomnia using pre-treatment heart rate variability in cancer patients Garneau J; Savard J; Dang-Vu TT; Gouin JP; 38991424
HKAP
10 Sleep spindles predict stress-related increases in sleep disturbances Dang-Vu TT; Salimi A; Boucetta S; Wenzel K; O' Byrne J; Brandewinder M; Berthomier C; Gouin JP; 25713529
PERFORM
11 High-frequency heart rate variability during worry predicts stress-related increases in sleep disturbances Gouin JP; Wenzel K; Boucetta S; O' Byrne J; Salimi A; Dang-Vu TT; 25819418
PERFORM
12 Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder Arnold V; Ancoli-Israel S; Dang-Vu TT; Mishima K; Pinner K; Malhotra M; Moline M; 38748321
HKAP
13 Methodological approach to sleep state misperception in insomnia disorder: Comparison between multiple nights of actigraphy recordings and a single night of polysomnography recording Maltezos A; Perrault AA; Walsh NA; Phillips EM; Gong K; Tarelli L; Smith D; Cross NE; Pomares FB; Gouin JP; Dang-Vu TT; 38325157
HKAP
14 Economic burden of insomnia symptoms in Canada Chaput JP; Janssen I; Sampasa-Kanyinga H; Carney CE; Dang-Vu TT; Davidson JR; Robillard R; Morin CM; 36319579
PERFORM
15 Insomnia disorder increases the risk of subjective memory decline in middle-aged and older adults: a longitudinal analysis of the Canadian Longitudinal Study on Aging Zhao JL; Cross N; Yao CW; Carrier J; Postuma RB; Gosselin N; Kakinami L; Dang-Vu TT; 35877203
PERFORM
16 Sleep disorders in patients with a neurocognitive disorder C Moderie 34916075
PERFORM
17 Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the CLSA Yao CW; Pelletier A; Fereshtehnejad SM; Cross N; Dang-Vu T; Postuma RB; 34314348
PERFORM
18 More than a quarter century of the most prescribed sleeping pill: Systematic review of zolpidem use by older adults. Machado FV, Louzada LL, Cross NE, Camargos EF, Dang-Vu TT, Nóbrega OT 32360985
PERFORM
19 Inactograms and objective sleep measures as means to capture subjective sleep problems in patients with a bipolar disorder. Lavin-Gonzalez P, Bourguignon C, Crescenzi O, Beaulieu S, Storch KF, Linnaranta O 32232937
PSYCHOLOGY
20 Failure of fear extinction in insomnia: An evolutionary perspective. Perogamvros L, Castelnovo A, Samson D, Dang-Vu TT 32143023
PERFORM
21 High-Frequency Heart Rate Variability Reactivity and Trait Worry Interact to Predict the Development of Sleep Disturbances in Response to a Naturalistic Stressor. MacNeil S, Deschênes SS, Caldwell W, Brouillard M, Dang-Vu TT, Gouin JP 28527014
PERFORM
22 Sleep spindles may predict response to cognitive-behavioral therapy for chronic insomnia Dang-Vu TT; Hatch B; Salimi A; Mograss M; Boucetta S; O' Byrne J; Brandewinder M; Berthomier C; Gouin JP; 29157588
PERFORM
23 Cortical Thinning and Altered Cortico-Cortical Structural Covariance of the Default Mode Network in Patients with Persistent Insomnia Symptoms. Suh S, Kim H, Dang-Vu TT, Joo E, Shin C 26414892
PERFORM
24 Association between insomnia disorder and cognitive function in middle-aged and older adults: a cross-sectional analysis of the Canadian Longitudinal Study on Aging Cross NE; Carrier J; Postuma RB; Gosselin N; Kakinami L; Thompson C; Chouchou F; Dang-Vu TT; 31089710
PERFORM

 

Title:Prevalence of insomnia and use of sleep aids among adults in Canada
Authors:Morin CMVézina-Im LAChen SJIvers HCarney CEChaput JPDang-Vu TTDavidson JRBelleville GLorrain DHorn ORobillard R
Link:https://pubmed.ncbi.nlm.nih.gov/39369578/
DOI:10.1016/j.sleep.2024.09.044
Publication:Sleep medicine
Keywords:AdultsAlcoholCannabisInsomniaMedicationPrevalenceRepresentative sample
PMID:39369578 Category: Date Added:2024-10-07
Dept Affiliation: HKAP
1 École de psychologie, Université Laval, 2325 rue des Bibliothèques, Québec, Québec, G1V 0A6, Canada; Centre d'étude des troubles du sommeil, Université Laval, 2325 rue des Bibliothèques, Québec, Québec, G1V 0A6, Canada. Electronic address: cmorin@psy.ulaval.ca.
2 École de psychologie, Université Laval, 2325 rue des Bibliothèques, Québec, Québec, G1V 0A6, Canada; Centre d'étude des troubles du sommeil, Université Laval, 2325 rue des Bibliothèques, Québec, Québec, G1V 0A6, Canada.
3 Department of Psychology, Toronto Metropolitan University, 350 Victoria Street, Toronto, Ontario, M5B 2K3, Canada.
4 Department of Pediatrics, University of Ottawa, 401 Smyth Road, Ottawa, Ontario, K1H 8L1, Canada; Healthy Active Living and Obesity Research Group, Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, Ontario, K1H 8L1, Canada.
5 Department of Health, Kinesiology and Applied Physiology, Concordia University, 7141 Sherbrooke Street West, Montréal, Québec, H4B 1R6, Canada; Centre de recherche de l'Institut universitaire de gériatrie de Montréal (CRIUGM), CIUSSS du Centre-Sud-de-l'île-de-Montréal, 4565 Queen Mary Road, Montréal, Québec, H3W 1W5, Canada.
6 Department of Psychology, Queen's University, 62 Arch Street, Kingston, Ontario, K7L 3N6, Canada.
7 École de psychologie, Université Laval, 2325 rue des Bibliothèques, Québec, Québec, G1V 0A6, Canada.
8 Département de psychologie, Université de Sherbrooke, 2500, boul. de l'Université, Sherbrooke, Québec, J1K 2R1, Canada.
9 Akwesasne Medical Clinic, 101 Tewesateni Road, Akwesasne, Ontario, K6H 0G5, Canada; Department of Family Medicine, McGill University, 5858 Chemin de la Côte-des-Neiges, Montréal, Québec, H3S 1Z1, Canada.
10 School of Psychology, University of Ottawa, 136 Jean-Jacques Lussier, Vanier Hall, Ottawa, Ontario, K1N 6N5, Canada; Sleep Research Unit, University of Ottawa Institute of Mental Health Research at the Royal, 1145 Carling Avenue, Ottawa, Ontario, K1Z 7K4, Canada.

Description:

Objectives: To estimate the prevalence of insomnia and the use of sleep aids among Canadian adults.

Methods: Data were derived from a phone interview conducted (April to October 2023) with a stratified, population-based sample of 4037 adults (57.6 % females; mean age 50.6 ± 18.4; range 18-102 years old) living in Canada. Post-stratified survey weights were included in the analysis to ensure the representativity of the adult Canadian population.

Results: The prevalence estimate of insomnia disorder was 16.3 % (95 % CI 15.1-17.6), with higher rates in females (risk ratio [RR] 1.24, 95 % CI 1.06-1.45), Indigenous peoples (RR 1.77, 95 % CI 1.27-2.47), and individuals with poorer mental or physical health. Overall, 14.7 % of respondents reported having used prescribed sleep medications in the previous 12 months, 28.7 % used natural products or over-the-counter (OTC) sleep aids, 15.6 % used cannabis-derived products and 9.7 % used alcohol for sleep in the last 12 months. Higher proportions of females used prescribed medication (RR 1.79, 95 % CI 1.31-2.43) and natural products or OTC medication (RR 1.41, 95 % CI 1.16-1.71), while more males used cannabis (RR 1.33, 95 % CI 1.03-1.72) and alcohol (RR 1.67, 95 % CI 1.16-2.33) for sleep. Higher proportions of older adults (=65 years) were taking prescribed medications, while more young adults (18-35 years) used natural products or OTC medications, cannabis, and alcohol as sleep aids.

Conclusions: Insomnia is a highly prevalent condition in Canada and there is widespread and increasing use of various medications and substances to cope with this health issue. These findings highlight the need for public health interventions to promote healthy sleep and for wider dissemination of evidence-based treatments for insomnia, such as cognitive behavioral therapy which is the first-line treatment for insomnia in practice guidelines, to reduce sleep health disparities.





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University